Global law firm Reed Smith announced that it served as legal counsel to its long-time client Adagio Medical, a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, on the completion of its business combination with ARYA Sciences Acquisition Corp IV, a special purpose acquisition company. Upon closing the transaction, the shares of common stock of the combined company, Adagio Medical Holdings, Inc., commenced trading under the ticker symbol “ADGM” on the Nasdaq Capital Market on August 1, 2024.
The cross-office Reed Smith M&A team advising Adagio Medical was led by partners Michael Sanders, Jennifer W. Cheng, and Susan Nieto, based in Los Angeles, New York, and Philadelphia, respectively. Critical support for this transaction was provided by New York partners Michael S. Lee and Ian Sherwin, Chicago partner Ben Brimeyer, Orange County partner Christopher Raidy, and Pittsburgh partner Allison Sizemore, all in the firm’s corporate practice.
Original source can be found here.